Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable smart belt coaches back pain sufferers through exercises

NCT ID NCT07555795

Symptom relief Sponsor: Imperial College London Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a wearable belt that senses muscle activity and gives real-time feedback through a phone app to help people with chronic low back pain perform core exercises correctly. Forty adults with non-specific low back pain will be randomly assigned to use the belt plus standard care or standard care alone for 8 weeks. Researchers will measure changes in pain, disability, and exercise adherence to see if the biofeedback helps improve outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MMG-biofeedback belt (wearable device with sensors and mobile app)
What this could lead to
If it works, this could provide a simple, home-based tool to help people with chronic back pain exercise correctly and reduce their pain and disability.
What could go wrong
This is a small early-stage trial with only 40 participants, so results may not apply to everyone. The device may not significantly improve pain or adherence compared to standard care alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Over the age of 18 2. Non-specific LBP for at least 6 weeks in the past 12 months 3. Pain 4/10 on a visual analogue scale or more or Oswestry Disability Index over 20% Exclusion Criteria: 1. Serious spinal pathology ("red flags") such as: * History of malignancy with new onset back pain suggestive of recurrence. * Unexplained weight loss, fever, or systemic symptoms. * Recent significant trauma (e.g., fall from height, road traffic accident). * Suspected or confirmed spinal infection (e.g., discitis, osteomyelitis). * Cauda equina symptoms, including urinary retention/incontinence or saddle anaesthesia. * Progressive neurological deficit (e.g., worsening weakness, loss of reflexes). 2. Recent spinal surgery or invasive spinal procedures within the past 3 months. 3. Severe cardiovascular or respiratory disease that prevents safe participation in mild to moderate exercise (e.g., unstable angina, uncontrolled heart failure). 4. Pregnant women or those less than three months postpartum. 5. Known allergy to materials used in the belt (e.g., Lycra or related fabrics). 6. Cognitive impairment that prevents informed consent or ability to follow exercise instructions. 7. Concurrent participation in another intervention trial that may interfere with the study outcomes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low back pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low back pain Non-specific low back pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Imperial College London

    RECRUITING

    London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.